A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains
- 5 May 1988
- journal article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 333 (6168), 74-76
- https://doi.org/10.1038/333074a0
Abstract
Malaria vaccines are being developed against different stages in the parasite's life cycle, each increasing the opportunity to control malaria in its diverse settings. Sporozoite vaccines are designed to prevent mosquito-induced infection; first generation recombinant or synthetic peptide vaccines have been tested in humans. Asexual erythrocytic stage vaccines, developed to prevent or reduce the severity of disease, have been tested in animals and in humans. A third strategy is to produce sexual stage vaccines that would induce antibodies which would prevent infection of mosquitoes when ingested in a bloodmeal containing sexual stage parasites. Although not directly protective, the sexual stage vaccine combined with a sporozoite or asexual stage vaccine (protective component) could prolong the useful life of the protective component by reducing transmission of resistant vaccine-induced mutants. In areas of low endemnicity, the sexual stage vaccine could reduce transmission below the critical threshold required to maintain the infected population, thereby assisting in the control or eradication of malaria. Transmission of Plasmodium falciparum, the major human malaria, can be blocked by monoclonal antibodies against three sexual stage-specific antigens. We have cloned the gene encoding the surface protein of relative molecular mass Mr 25,000 (25K; Pfs25), expressed on zygotes and ookinetes of P. falciparum. The deduced amino-acid sequence consists of a signal sequence, a hydrophobic C-terminus, and four tandem epidermal growth factor EGF-like domains.Keywords
This publication has 26 references indexed in Scilit:
- Structural and Functional Roles of Glycosyl-Phosphatidylinositol in MembranesScience, 1988
- Mortality and morbidity from malaria among children in a rural area of The Gambia, West AfricaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1987
- Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoitesNature, 1987
- Research Toward Malaria VaccinesScience, 1986
- lin-12, a nematode homeotic gene, is homologous to a set of mammalian proteins that includes epidermal growth factorCell, 1985
- Nucleotide sequence from the neurogenic locus Notch implies a gene product that shares homology with proteins containing EGF-like repeatsCell, 1985
- Amino Acid Homology Between the Encephalitogenic Site of Myelin Basic Protein and Virus: Mechanism for AutoimmunityScience, 1985
- Computer-based characterization of epidermal growth factor precursorNature, 1984
- Structure of a Mouse Submaxillary Messenger RNA Encoding Epidermal Growth Factor and Seven Related ProteinsScience, 1983
- Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursorNature, 1983